BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Fortress Biotech (Formerly Known As Coronado Biosciences) 

4365 Executive Drive
Suite 1500
San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Fortress Biotech (CNDO) Reports Financial Results For The First Quarter 2015 Ended March 31, 2015 5/11/2015 8:37:25 AM
Coronado Biosciences (CNDO) Changes Its Name To Fortress Biotech 4/27/2015 7:57:51 AM
Coronado Biosciences (CNDO) Forms New Subsidiary, Diavax Biosciences, To Develop Novel Immunotherapies For Cytomegalovirus 4/2/2015 7:14:26 AM
Coronado Biosciences (CNDO) Announces Exclusive Licensing Agreement With Neupharma To Develop And Commercialize Novel Covalent 3rd Generation EGFR Inhibitors 3/19/2015 7:38:45 AM
New Company Mustang Therapeutics Formed by Coronado Biosciences (CNDO), City of Hope 3/19/2015 7:29:32 AM
Coronado Biosciences (CNDO) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 201 3/16/2015 7:53:29 AM
Coronado Biosciences (CNDO) Forms New Subsidiary, Checkpoint Therapeutics, To Develop Novel Immuno-Oncology Antibodies 3/4/2015 7:11:28 AM
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing 3/3/2015 7:10:55 AM
Coronado Biosciences (CNDO) In-Licenses IV Tramadol, A Phase III Ready Asset, From Revogenex Ireland Ltd. 2/18/2015 7:40:51 AM
Coronado Biosciences (CNDO) Reports On Separation Of CB Pharma Acquisition Corp. Securities 1/6/2015 7:45:35 AM
12345678910...